MRG004A

· Shanghai Miracogen Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for MRG004A, covering 2022-09-08 to 2025-08-24. Get the full timeline:

Most recent: Clinical Trial Update: A Study Comparing MRG004A Plus Best Supportive Care Versus Placebo and Best Supportive Care in the Treatment of Patients With Advanced Pancreatic Cancer [Phase 3]

See pricing